CIK 0001453687
- Non-accelerated filer
- Smaller reporting company
Cartesian Therapeutics, Inc.
Sign in to watch- Ticker
- RNAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 301-348-8698
- Business address
- 7495 NEW HORIZON WAY, FREDERICK, MD, 21703
- Former names
- SELECTA BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-30 | ZENNER PATRICK J Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2021-03-30 | SPRINGER TIMOTHY A Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2021-03-30 | Sallin Aymeric Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2021-03-30 | Myers Scott Dunseth Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2021-03-30 | COX CARRIE SMITH Director | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2021-03-30 | BARABE TIMOTHY C Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2021-03-26 | BARABE TIMOTHY C Director | Purchase | +10,000 | $4.10 | $41K | 181,013 |
| 2021-03-18 | TRABER PETER G Chief Medical Officer | Purchase | +10,000 | $4.50 | $45K | 98,000 |
| 2021-03-17 | TRABER PETER G Chief Medical Officer | Purchase | +10,000 | $4.53 | $45K | 88,000 |
| 2021-03-17 | Johnston Lloyd P. COO and SVP, R&D | Sale | −15,128 | $4.45 | $67K | 87,477 |
| 2021-03-02 | Brunn Carsten President and CEO | Sale | −5,461 | $4.26 | $23K | 216,826 |
| 2021-03-01 | Brunn Carsten President and CEO | Option exercise | +10,937 | 222,287 | ||
| 2021-03-01 | Brunn Carsten President and CEO | Option exercise · Restricted Stock Units | −10,937 | 76,563 | ||
| 2021-02-11 | Johnston Lloyd P. COO and SVP, R&D | Option exercise | +44,871 | $0.63 | $28K | 102,605 |
| 2021-02-11 | Johnston Lloyd P. COO and SVP, R&D | Option exercise · Employee Stock Option (right to buy) | −44,871 | 0 |
Page 25 of 25 · 495 trades